Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
35.50
-0.38 (-1.06%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Simulations Plus Market Cap

Simulations Plus has a market cap or net worth of $713.94 million as of April 28, 2025. Its market cap has decreased by -25.34% in one year.

Market Cap
713.94M
Enterprise Value
693.35M
1-Year Change
-25.34%
Ranking
Category
Stock Price
$35.50

Market Cap Chart

Since December 1, 1998, Simulations Plus's market cap has increased from $4.50M to $713.94M, an increase of 15,765.38%. That is a compound annual growth rate of 21.14%.

History

DateMarket Cap% Change
Apr 25, 2025713.90M27.55%
Dec 31, 2024559.70M-37.27%
Dec 29, 2023892.20M20.19%
Dec 30, 2022742.30M-22.11%
Dec 31, 2021953.00M-33.52%
Dec 31, 20201.43B179.82%
Dec 31, 2019512.30M47.76%
Dec 31, 2018346.70M24.58%
Dec 29, 2017278.30M67.45%
Dec 30, 2016166.20M-1.31%
Dec 31, 2015168.40M49.69%
Dec 31, 2014112.50M38.89%
Dec 31, 201381.00M15.88%
Dec 31, 201269.90M50.00%
Dec 30, 201146.60M11.75%
Dec 31, 201041.70M93.95%
Dec 31, 200921.50M42.38%
Dec 31, 200815.10M-75.25%
Dec 31, 200761.00M42.86%
Dec 29, 200642.70M125.93%
Dec 30, 200518.90M-5.03%
Dec 31, 200419.90M28.39%
Dec 31, 200315.50M89.02%
Dec 31, 20028.20M182.76%
Dec 31, 20012.90M-57.35%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 781.33B
UnitedHealth Group 381.13B
Johnson & Johnson 369.79B
AbbVie 328.30B
Novo Nordisk 276.96B
Abbott Laboratories 221.99B
AstraZeneca 215.41B
Novartis AG 211.71B
Market Cap Rankings